{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T23:59:00Z","timestamp":1785110340448,"version":"3.55.0"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T00:00:00Z","timestamp":1785110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81472650"],"award-info":[{"award-number":["81472650"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81673061"],"award-info":[{"award-number":["81673061"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82503132"],"award-info":[{"award-number":["82503132"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"DOI":"10.1038\/s41392-026-02777-3","type":"journal-article","created":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T23:01:04Z","timestamp":1785106864000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Chenodeoxycholic acid restrains tumor growth via TGR5-dependent type 1 dendritic cells cross-priming"],"prefix":"10.1038","volume":"11","author":[{"given":"Fanlian","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8866-4041","authenticated-orcid":false,"given":"Fulei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yawen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiadong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guolin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengcheng","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nongyu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinmeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shishi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxiang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenling","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaijun","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3742-630X","authenticated-orcid":false,"given":"Jiong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,27]]},"reference":[{"key":"2777_CR1","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.ccell.2017.04.003","volume":"31","author":"S Spranger","year":"2017","unstructured":"Spranger, S., Dai, D., Horton, B. & Gajewski, T. F. Tumor-residing Batf3 dendritic cells are required for effector T cell trafficking and adoptive t cell therapy. Cancer Cell 31, 711\u2013723.e714 (2017).","journal-title":"Cancer Cell"},{"key":"2777_CR2","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","volume":"20","author":"AD Waldman","year":"2020","unstructured":"Waldman, A. D., Fritz, J. M. & Lenardo, M. J. A guide to cancer immunotherapy: from T-cell basic science to clinical practice. Nat. Rev. Immunol. 20, 651\u2013668 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"2777_CR3","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.ccell.2016.06.003","volume":"30","author":"EW Roberts","year":"2016","unstructured":"Roberts, E. W. et al. Critical role for CD103(+)\/CD141(+) dendritic cells bearing CCR7 for tumor antigen trafficking and priming of T-cell immunity in melanoma. Cancer Cell 30, 324\u2013336 (2016).","journal-title":"Cancer Cell"},{"key":"2777_CR4","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.immuni.2016.03.012","volume":"44","author":"H Salmon","year":"2016","unstructured":"Salmon, H. et al. Expansion and activation of CD103(+) dendritic cell progenitors at the tumor site enhances tumor responses to therapeutic PD-L1 and BRAF inhibition. Immunity 44, 924\u2013938 (2016).","journal-title":"Immunity"},{"key":"2777_CR5","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1016\/j.immuni.2023.09.011","volume":"56","author":"I Mellman","year":"2023","unstructured":"Mellman, I., Chen, D. S., Powles, T. & Turley, S. J. The cancer-immunity cycle: indication, genotype, and immunotype. Immunity 56, 2188\u20132205 (2023).","journal-title":"Immunity"},{"key":"2777_CR6","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.ccell.2014.09.007","volume":"26","author":"ML Broz","year":"2014","unstructured":"Broz, M. L. et al. Dissecting the tumor myeloid compartment reveals rare activating antigen-presenting cells critical for T-cell immunity. Cancer Cell 26, 638\u2013652 (2014).","journal-title":"Cancer Cell"},{"key":"2777_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13368-y","volume":"10","author":"CR Perez","year":"2019","unstructured":"Perez, C. R. & De Palma, M. Engineering dendritic cell vaccines to improve cancer immunotherapy. Nat. Commun. 10, 5408 (2019).","journal-title":"Nat. Commun."},{"key":"2777_CR8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41577-019-0210-z","volume":"20","author":"SK Wculek","year":"2020","unstructured":"Wculek, S. K. et al. Dendritic cells in cancer immunology and immunotherapy. Nat. Rev. Immunol. 20, 7\u201324 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"2777_CR9","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1016\/j.immuni.2022.09.015","volume":"55","author":"BW MacNabb","year":"2022","unstructured":"MacNabb, B. W. et al. Dendritic cells can prime anti-tumor CD8(+) T-cell responses through major histocompatibility complex cross-dressing. Immunity 55, 2206\u20132208 (2022).","journal-title":"Immunity"},{"key":"2777_CR10","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41568-021-00339-z","volume":"21","author":"S Jhunjhunwala","year":"2021","unstructured":"Jhunjhunwala, S., Hammer, C. & Delamarre, L. Antigen presentation in cancer: insights into tumor immunogenicity and immune evasion. Nat. Rev. Cancer 21, 298\u2013312 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"2777_CR11","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1084\/jem.171.2.377","volume":"171","author":"FR Carbone","year":"1990","unstructured":"Carbone, F. R. & Bevan, M. J. Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo. J. Exp. Med. 171, 377\u2013387 (1990).","journal-title":"J. Exp. Med."},{"key":"2777_CR12","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1126\/science.7513904","volume":"264","author":"AY Huang","year":"1994","unstructured":"Huang, A. Y. et al. Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science 264, 961\u2013965 (1994).","journal-title":"Science"},{"key":"2777_CR13","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/164_2019_226","volume":"256","author":"S Fiorucci","year":"2019","unstructured":"Fiorucci, S. & Distrutti, E. Chenodeoxycholic acid: an update on its therapeutic applications. Handb. Exp. Pharmacol. 256, 265\u2013282 (2019).","journal-title":"Handb. Exp. Pharmacol."},{"key":"2777_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102452","volume":"56","author":"J Liu","year":"2022","unstructured":"Liu, J. et al. Chenodeoxycholic acid suppresses AML progression through promoting lipid peroxidation via ROS\/p38 MAPK\/DGAT1 pathway and inhibiting M2 macrophage polarization. Redox Biol. 56, 102452 (2022).","journal-title":"Redox Biol."},{"key":"2777_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2022.174925","volume":"923","author":"D Shen","year":"2022","unstructured":"Shen, D. et al. Chenodeoxycholic acid inhibits lung adenocarcinoma progression via the integrin alpha5beta1\/FAK\/p53 signaling pathway. Eur. J. Pharmacol. 923, 174925 (2022).","journal-title":"Eur. J. Pharmacol."},{"key":"2777_CR16","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1002\/ijc.21917","volume":"119","author":"T Soma","year":"2006","unstructured":"Soma, T. et al. Chenodeoxycholic acid stimulates the progression of human esophageal cancer cells: a possible mechanism of angiogenesis in patients with esophageal cancer. Int. J. Cancer 119, 771\u2013782 (2006).","journal-title":"Int. J. Cancer"},{"key":"2777_CR17","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1097\/HEP.0000000000000957","volume":"81","author":"S Yang","year":"2025","unstructured":"Yang, S. et al. Bile metabolic fingerprints distinguish biliary tract cancer from benign biliary diseases. Hepatology 81, 476\u2013490 (2025).","journal-title":"Hepatology"},{"key":"2777_CR18","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/nature02284","volume":"427","author":"M Matloubian","year":"2004","unstructured":"Matloubian, M. et al. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 427, 355\u2013360 (2004).","journal-title":"Nature"},{"key":"2777_CR19","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1126\/science.1164206","volume":"322","author":"K Hildner","year":"2008","unstructured":"Hildner, K. et al. Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T-cell immunity. Science 322, 1097\u20131100 (2008).","journal-title":"Science"},{"key":"2777_CR20","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1080\/19490976.2020.1732268","volume":"11","author":"Y Tian","year":"2020","unstructured":"Tian, Y. et al. The microbiome modulating activity of bile acids. Gut Microbes 11, 979\u2013996 (2020).","journal-title":"Gut Microbes"},{"key":"2777_CR21","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/s41579-022-00805-x","volume":"21","author":"SL Collins","year":"2023","unstructured":"Collins, S. L., Stine, J. G., Bisanz, J. E., Okafor, C. D. & Patterson, A. D. Bile acids and the gut microbiota: metabolic interactions and impacts on disease. Nat. Rev. Microbiol. 21, 236\u2013247 (2023).","journal-title":"Nat. Rev. Microbiol."},{"key":"2777_CR22","doi-asserted-by":"publisher","first-page":"102970","DOI":"10.1016\/j.copbio.2023.102970","volume":"83","author":"JJ Apiz Saab","year":"2023","unstructured":"Apiz Saab, J. J. & Muir, A. Tumor interstitial fluid analysis enables the study of microenvironment-cell interactions in cancers. Curr. Opin. Biotechnol. 83, 102970 (2023).","journal-title":"Curr. Opin. Biotechnol."},{"key":"2777_CR23","doi-asserted-by":"crossref","unstructured":"Sullivan, M. R. et al. Quantification of microenvironmental metabolites in murine cancers reveals determinants of tumor nutrient availability. eLife 8, e44235 (2019).","DOI":"10.7554\/eLife.44235"},{"key":"2777_CR24","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/nrd2619","volume":"7","author":"C Thomas","year":"2008","unstructured":"Thomas, C., Pellicciari, R., Pruzanski, M., Auwerx, J. & Schoonjans, K. Targeting bile-acid signaling for metabolic diseases. Nat. Rev. Drug Discov. 7, 678\u2013693 (2008).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2777_CR25","doi-asserted-by":"publisher","first-page":"13580","DOI":"10.1073\/pnas.0804437105","volume":"105","author":"BV Jones","year":"2008","unstructured":"Jones, B. V., Begley, M., Hill, C., Gahan, C. G. & Marchesi, J. R. Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome. Proc. Natl. Acad. Sci. USA 105, 13580\u201313585 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2777_CR26","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.chom.2022.02.004","volume":"30","author":"J Cai","year":"2022","unstructured":"Cai, J., Sun, L. & Gonzalez, F. J. Gut microbiota-derived bile acids in intestinal immunity, inflammation, and tumorigenesis. Cell Host Microbe 30, 289\u2013300 (2022).","journal-title":"Cell Host Microbe"},{"key":"2777_CR27","doi-asserted-by":"crossref","unstructured":"Xie, C. et al. Role of bile acids in the regulation of food intake, and their dysregulation in metabolic disease. Nutrients 13, 1104 (2021).","DOI":"10.3390\/nu13041104"},{"key":"2777_CR28","doi-asserted-by":"publisher","first-page":"333","DOI":"10.2165\/00003088-199630050-00002","volume":"30","author":"A Crosignani","year":"1996","unstructured":"Crosignani, A. et al. Clinical pharmacokinetics of therapeutic bile acids. Clin. Pharmacokinet. 30, 333\u2013358 (1996).","journal-title":"Clin. Pharmacokinet."},{"key":"2777_CR29","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.cmet.2015.07.002","volume":"22","author":"EP Broeders","year":"2015","unstructured":"Broeders, E. P. et al. The bile acid chenodeoxycholic acid increases human brown adipose tissue activity. Cell Metab. 22, 418\u2013426 (2015).","journal-title":"Cell Metab."},{"key":"2777_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02068-0","volume":"9","author":"LA Velazquez-Villegas","year":"2018","unstructured":"Velazquez-Villegas, L. A. et al. TGR5 signaling promotes mitochondrial fission and beige remodeling of white adipose tissue. Nat. Commun. 9, 245 (2018).","journal-title":"Nat. Commun."},{"key":"2777_CR31","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1152\/physrev.00010.2008","volume":"89","author":"P Lefebvre","year":"2009","unstructured":"Lefebvre, P., Cariou, B., Lien, F., Kuipers, F. & Staels, B. Role of bile acids and bile acid receptors in metabolic regulation. Physiol. Rev. 89, 147\u2013191 (2009).","journal-title":"Physiol. Rev."},{"key":"2777_CR32","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41392-024-01811-6","volume":"9","author":"JS Fleishman","year":"2024","unstructured":"Fleishman, J. S. & Kumar, S. Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets. Signal Transduct. Target. Ther. 9, 97 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"key":"2777_CR33","doi-asserted-by":"publisher","first-page":"3230","DOI":"10.1194\/jlr.M007641","volume":"51","author":"Y Zhang","year":"2010","unstructured":"Zhang, Y. & Klaassen, C. D. Effects of feeding bile acids and a bile acid sequestrant on hepatic bile acid composition in mice. J. Lipid Res. 51, 3230\u20133242 (2010).","journal-title":"J. Lipid Res."},{"key":"2777_CR34","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/s41586-021-03832-5","volume":"599","author":"Y Sato","year":"2021","unstructured":"Sato, Y. et al. Novel bile acid biosynthetic pathways are enriched in the microbiome of centenarians. Nature 599, 458\u2013464 (2021).","journal-title":"Nature"},{"key":"2777_CR35","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1021\/acs.jafc.6b05428","volume":"65","author":"MM Zheng","year":"2017","unstructured":"Zheng, M. M. et al. Engineering 7beta-hydroxysteroid dehydrogenase for enhanced ursodeoxycholic acid production by multiobjective directed evolution. J. Agric. Food Chem. 65, 1178\u20131185 (2017).","journal-title":"J. Agric. Food Chem."},{"key":"2777_CR36","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cmet.2013.03.013","volume":"17","author":"TQ de Aguiar Vallim","year":"2013","unstructured":"de Aguiar Vallim, T. Q., Tarling, E. J. & Edwards, P. A. Pleiotropic roles of bile acids in metabolism. Cell Metab. 17, 657\u2013669 (2013).","journal-title":"Cell Metab."},{"key":"2777_CR37","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1126\/science.adl4100","volume":"387","author":"SK Varanasi","year":"2025","unstructured":"Varanasi, S. K. et al. Bile acid synthesis impedes tumor-specific T-cell responses during liver cancer. Science 387, 192\u2013201 (2025).","journal-title":"Science"},{"key":"2777_CR38","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/32588","volume":"392","author":"J Banchereau","year":"1998","unstructured":"Banchereau, J. & Steinman, R. M. Dendritic cells and the control of immunity. Nature 392, 245\u2013252 (1998).","journal-title":"Nature"},{"key":"2777_CR39","doi-asserted-by":"crossref","unstructured":"Zhou, Y. et al. Activation of NF-kappaB and p300\/CBP potentiates cancer chemoimmunotherapy through induction of MHC-I antigen presentation. Proc. Natl. Acad. Sci. USA 118, e2025840118 (2021).","DOI":"10.1073\/pnas.2025840118"},{"key":"2777_CR40","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/s41577-022-00707-2","volume":"22","author":"N Pishesha","year":"2022","unstructured":"Pishesha, N., Harmand, T. J. & Ploegh, H. L. A guide to antigen processing and presentation. Nat. Rev. Immunol. 22, 751\u2013764 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"2777_CR41","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/nri3339","volume":"12","author":"KS Kobayashi","year":"2012","unstructured":"Kobayashi, K. S. & van den Elsen, P. J. NLRC5: a key regulator of MHC class I-dependent immune responses. Nat. Rev. Immunol. 12, 813\u2013820 (2012).","journal-title":"Nat. Rev. Immunol."},{"key":"2777_CR42","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1038\/embor.2011.203","volume":"12","author":"N Merzougui","year":"2011","unstructured":"Merzougui, N., Kratzer, R., Saveanu, L. & van Endert, P. A proteasome dependent, TAP-independent pathway for cross-presentation of phagocytosed antigen. EMBO Rep. 12, 1257\u20131264 (2011).","journal-title":"EMBO Rep."},{"key":"2777_CR43","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nri3254","volume":"12","author":"OP Joffre","year":"2012","unstructured":"Joffre, O. P., Segura, E., Savina, A. & Amigorena, S. Cross-presentation by dendritic cells. Nat. Rev. Immunol. 12, 557\u2013569 (2012).","journal-title":"Nat. Rev. Immunol."},{"key":"2777_CR44","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nrgastro.2013.151","volume":"11","author":"FG Schaap","year":"2014","unstructured":"Schaap, F. G., Trauner, M. & Jansen, P. L. Bile acid receptors as targets for drug development. Nat. Rev. Gastroenterol. Hepatol. 11, 55\u201367 (2014).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"2777_CR45","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.immuni.2016.09.008","volume":"45","author":"C Guo","year":"2016","unstructured":"Guo, C. et al. Bile acids control inflammation and metabolic disorder through inhibition of NLRP3 inflammasome. Immunity 45, 802\u2013816 (2016).","journal-title":"Immunity"},{"key":"2777_CR46","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s40164-020-00191-1","volume":"9","author":"H Zhang","year":"2020","unstructured":"Zhang, H., Kong, Q., Wang, J., Jiang, Y. & Hua, H. Complex roles of cAMP-PKA-CREB signaling in cancer. Exp. Hematol. Oncol. 9, 32 (2020).","journal-title":"Exp. Hematol. Oncol."},{"key":"2777_CR47","first-page":"898","volume":"18","author":"YC Qi","year":"2020","unstructured":"Qi, Y. C. et al. Taurochenodeoxycholic acid mediates cAMP-PKA-CREB signaling pathway. Chin. J. Nat. Med. 18, 898\u2013906 (2020).","journal-title":"Chin. J. Nat. Med."},{"key":"2777_CR48","doi-asserted-by":"publisher","first-page":"E1800","DOI":"10.1073\/pnas.1418716112","volume":"112","author":"S Susuki-Miyata","year":"2015","unstructured":"Susuki-Miyata, S. et al. Cross-talk between PKA-Cbeta and p65 mediates synergistic induction of PDE4B by roflumilast and NTHi. Proc. Natl. Acad. Sci. USA 112, E1800\u2013E1809 (2015).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2777_CR49","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nrc3258","volume":"12","author":"K Palucka","year":"2012","unstructured":"Palucka, K. & Banchereau, J. Cancer immunotherapy via dendritic cells. Nat. Rev. Cancer 12, 265\u2013277 (2012).","journal-title":"Nat. Rev. Cancer"},{"key":"2777_CR50","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/nm1039","volume":"10","author":"CG Figdor","year":"2004","unstructured":"Figdor, C. G., de Vries, I. J., Lesterhuis, W. J. & Melief, C. J. Dendritic cell immunotherapy: mapping the way. Nat. Med. 10, 475\u2013480 (2004).","journal-title":"Nat. Med."},{"key":"2777_CR51","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.immuni.2011.09.007","volume":"35","author":"D Hashimoto","year":"2011","unstructured":"Hashimoto, D., Miller, J. & Merad, M. Dendritic cell and macrophage heterogeneity in vivo. Immunity 35, 323\u2013335 (2011).","journal-title":"Immunity"},{"key":"2777_CR52","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/nri.2016.80","volume":"16","author":"DE Speiser","year":"2016","unstructured":"Speiser, D. E., Ho, P. C. & Verdeil, G. Regulatory circuits of T-cell function in cancer. Nat. Rev. Immunol. 16, 599\u2013611 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"2777_CR53","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1146\/annurev-med-012017-043208","volume":"69","author":"M Hashimoto","year":"2018","unstructured":"Hashimoto, M. et al. CD8 T-cell exhaustion in chronic infection and cancer: opportunities for interventions. Annu. Rev. Med. 69, 301\u2013318 (2018).","journal-title":"Annu. Rev. Med."},{"key":"2777_CR54","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1158\/2159-8290.CD-15-0510","volume":"6","author":"AR Sanchez-Paulete","year":"2016","unstructured":"Sanchez-Paulete, A. R. et al. Cancer immunotherapy with immunomodulatory anti-CD137 and anti-PD-1 monoclonal antibodies requires BATF3-dependent dendritic cells. Cancer Discov. 6, 71\u201379 (2016).","journal-title":"Cancer Discov."},{"key":"2777_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2023.166837","volume":"903","author":"J Liu","year":"2023","unstructured":"Liu, J. et al. Chronic cold environment regulates rheumatoid arthritis through modulation of gut microbiota-derived bile acids. Sci. Total Environ. 903, 166837 (2023).","journal-title":"Sci. Total Environ."},{"key":"2777_CR56","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.immuni.2024.02.014","volume":"57","author":"J Cong","year":"2024","unstructured":"Cong, J. et al. Bile acids modified by the intestinal microbiota promote colorectal cancer growth by suppressing CD8(+) T-cell effector functions. Immunity 57, 876\u2013889.e811 (2024).","journal-title":"Immunity"},{"key":"2777_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31141-6","volume":"13","author":"Y Shen","year":"2022","unstructured":"Shen, Y. et al. Ursodeoxycholic acid reduces antitumor immunosuppression by inducing CHIP-mediated TGF-beta degradation. Nat. Commun. 13, 3419 (2022).","journal-title":"Nat. Commun."},{"key":"2777_CR58","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1016\/j.cmet.2023.09.011","volume":"35","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y. et al. Dietary fructose-mediated adipocyte metabolism drives antitumor CD8(+) T-cell responses. Cell Metab. 35, 2107\u20132118.e2106 (2023).","journal-title":"Cell Metab."},{"key":"2777_CR59","doi-asserted-by":"crossref","unstructured":"Klinke, D. J., 2nd, Gould, A., Pirkey, A., Razazan, A. & Deng, W. A functional comparison of two transplantable syngeneic mouse models of melanoma: B16F0 and YUMM1.7. Biol. Open 14, bio062175 (2025).","DOI":"10.1242\/bio.062175"},{"key":"2777_CR60","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/nature04330","volume":"439","author":"M Watanabe","year":"2006","unstructured":"Watanabe, M. et al. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature 439, 484\u2013489 (2006).","journal-title":"Nature"},{"key":"2777_CR61","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3389\/fonc.2015.00115","volume":"5","author":"M Wagner","year":"2015","unstructured":"Wagner, M. & Wiig, H. Tumor interstitial fluid formation, characterization, and clinical implications. Front. Oncol. 5, 115 (2015).","journal-title":"Front. Oncol."},{"key":"2777_CR62","doi-asserted-by":"publisher","first-page":"793","DOI":"10.2217\/14796694.4.6.793","volume":"4","author":"SJ Lunt","year":"2008","unstructured":"Lunt, S. J., Fyles, A., Hill, R. P. & Milosevic, M. Interstitial fluid pressure in tumors: therapeutic barrier and biomarker of angiogenesis. Future Oncol. 4, 793\u2013802 (2008).","journal-title":"Future Oncol."},{"key":"2777_CR63","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.immuni.2016.10.009","volume":"45","author":"C Guo","year":"2016","unstructured":"Guo, C. et al. Bile acids control inflammation and metabolic disorder through inhibition of NLRP3 inflammasome. Immunity 45, 944 (2016).","journal-title":"Immunity"},{"key":"2777_CR64","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1002\/cam4.1965","volume":"8","author":"T Pearson","year":"2019","unstructured":"Pearson, T. et al. Effects of ursodeoxycholic acid on the gut microbiome and colorectal adenoma development. Cancer Med. 8, 617\u2013628 (2019).","journal-title":"Cancer Med."},{"key":"2777_CR65","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.ymthe.2022.10.014","volume":"31","author":"Q He","year":"2023","unstructured":"He, Q. et al. Therapeutic role of ursodeoxycholic acid in colitis-associated cancer via gut microbiota modulation. Mol. Ther. 31, 585\u2013598 (2023).","journal-title":"Mol. Ther."},{"key":"2777_CR66","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2022.2120744","volume":"14","author":"D Jin","year":"2022","unstructured":"Jin, D. et al. Deoxycholic acid induces gastric intestinal metaplasia by activating STAT3 signaling and disturbing gastric bile acids metabolism and microbiota. Gut Microbes 14, 2120744 (2022).","journal-title":"Gut Microbes"},{"key":"2777_CR67","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41591-021-01655-5","volume":"28","author":"L Derosa","year":"2022","unstructured":"Derosa, L. et al. Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small cell lung cancer. Nat. Med. 28, 315\u2013324 (2022).","journal-title":"Nat. Med."},{"key":"2777_CR68","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1136\/gutjnl-2022-327853","volume":"72","author":"Y Jiang","year":"2023","unstructured":"Jiang, Y. et al. Acetyltransferase from Akkermansia muciniphila blunts colorectal tumorigenesis by reprogramming tumor microenvironment. Gut 72, 1308\u20131318 (2023).","journal-title":"Gut"},{"key":"2777_CR69","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/s41575-022-00631-9","volume":"19","author":"PD Cani","year":"2022","unstructured":"Cani, P. D., Depommier, C., Derrien, M., Everard, A. & de Vos, W. M. Akkermansia muciniphila: paradigm for next-generation beneficial microorganisms. Nat. Rev. Gastroenterol. Hepatol. 19, 625\u2013637 (2022).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"2777_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101900","volume":"6","author":"XQ Wu","year":"2025","unstructured":"Wu, X. Q. et al. Intestinal Akkermansia muciniphila complements the efficacy of PD1 therapy in MAFLD-related hepatocellular carcinoma. Cell Rep. Med. 6, 101900 (2025).","journal-title":"Cell Rep. Med."},{"key":"2777_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114306","volume":"43","author":"Z Zhu","year":"2024","unstructured":"Zhu, Z. et al. Landscape of tumoral ecosystem for enhanced anti-PD-1 immunotherapy by gut Akkermansia muciniphila. Cell Rep. 43, 114306 (2024).","journal-title":"Cell Rep."},{"key":"2777_CR72","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41586-019-1785-z","volume":"576","author":"S Hang","year":"2019","unstructured":"Hang, S. et al. Bile acid metabolites control T(H)17 and T(reg) cell differentiation. Nature 576, 143\u2013148 (2019).","journal-title":"Nature"},{"key":"2777_CR73","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/ni.2768","volume":"15","author":"PB Watchmaker","year":"2014","unstructured":"Watchmaker, P. B. et al. Comparative transcriptional and functional profiling defines conserved programs of intestinal DC differentiation in humans and mice. Nat. Immunol. 15, 98\u2013108 (2014).","journal-title":"Nat. Immunol."},{"key":"2777_CR74","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46966-6","volume":"15","author":"H Xiao","year":"2024","unstructured":"Xiao, H. et al. Genomic deletion of Bcl6 differentially affects conventional dendritic cell subsets and compromises Tfh\/Tfr\/Th17 cell responses. Nat. Commun. 15, 3554 (2024).","journal-title":"Nat. Commun."},{"key":"2777_CR75","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/ijc.21303","volume":"118","author":"NF Watson","year":"2006","unstructured":"Watson, N. F. et al. Immunosurveillance is active in colorectal cancer as downregulation but not complete loss of MHC class I expression correlates with a poor prognosis. Int. J. Cancer 118, 6\u201310 (2006).","journal-title":"Int. J. Cancer"},{"key":"2777_CR76","first-page":"6372","volume":"51","author":"C Cordon-Cardo","year":"1991","unstructured":"Cordon-Cardo, C. et al. Expression of HLA-A,B,C antigens on primary and metastatic tumor cell populations of human carcinomas. Cancer Res. 51, 6372\u20136380 (1991).","journal-title":"Cancer Res."},{"key":"2777_CR77","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01062-w","volume":"8","author":"M Sade-Feldman","year":"2017","unstructured":"Sade-Feldman, M. et al. Resistance to checkpoint blockade therapy through inactivation of antigen presentation. Nat. Commun. 8, 1136 (2017).","journal-title":"Nat. Commun."},{"key":"2777_CR78","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1126\/science.aao4572","volume":"359","author":"D Chowell","year":"2018","unstructured":"Chowell, D. et al. Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy. Science 359, 582\u2013587 (2018).","journal-title":"Science"},{"key":"2777_CR79","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06300-3","volume":"9","author":"KG Paulson","year":"2018","unstructured":"Paulson, K. G. et al. Acquired cancer resistance to combination immunotherapy from transcriptional loss of class I HLA. Nat. Commun. 9, 3868 (2018).","journal-title":"Nat. Commun."},{"key":"2777_CR80","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nrg3185","volume":"13","author":"C Vogel","year":"2012","unstructured":"Vogel, C. & Marcotte, E. M. Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nat. Rev. Genet. 13, 227\u2013232 (2012).","journal-title":"Nat. Rev. Genet."},{"key":"2777_CR81","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/nrm1368","volume":"5","author":"LF Chen","year":"2004","unstructured":"Chen, L. F. & Greene, W. C. Shaping the nuclear action of NF-kappaB. Nat. Rev. Mol. Cell Biol. 5, 392\u2013401 (2004).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"2777_CR82","doi-asserted-by":"publisher","first-page":"766","DOI":"10.3389\/fimmu.2019.00766","volume":"10","author":"B Mastelic-Gavillet","year":"2019","unstructured":"Mastelic-Gavillet, B., Balint, K., Boudousquie, C., Gannon, P. O. & Kandalaft, L. E. Personalized dendritic cell vaccines-recent breakthroughs and encouraging clinical results. Front. Immunol. 10, 766 (2019).","journal-title":"Front. Immunol."},{"key":"2777_CR83","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.omto.2019.03.007","volume":"13","author":"RA Belderbos","year":"2019","unstructured":"Belderbos, R. A., Aerts, J. & Vroman, H. Enhancing dendritic cell therapy in solid tumors with immunomodulating conventional treatment. Mol. Ther. Oncolytics 13, 67\u201381 (2019).","journal-title":"Mol. Ther. Oncolytics"},{"key":"2777_CR84","doi-asserted-by":"publisher","DOI":"10.1126\/science.adh4567","volume":"384","author":"KK Mahadevan","year":"2024","unstructured":"Mahadevan, K. K. et al. Type I conventional dendritic cells facilitate immunotherapy in pancreatic cancer. Science 384, eadh4567 (2024).","journal-title":"Science"},{"key":"2777_CR85","doi-asserted-by":"crossref","unstructured":"Anfray, C. et al. Intratumoral combination therapy with poly(I:C) and resiquimod synergistically triggers tumor-associated macrophages for effective systemic antitumoral immunity. J. Immunother. Cancer 9, e002408 (2021).","DOI":"10.1136\/jitc-2021-002408"},{"key":"2777_CR86","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1056\/NEJMoa020177","volume":"348","author":"L Zhang","year":"2003","unstructured":"Zhang, L. et al. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N. Engl. J. Med. 348, 203\u2013213 (2003).","journal-title":"N. Engl. J. Med."},{"key":"2777_CR87","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15095","volume":"8","author":"JL Carstens","year":"2017","unstructured":"Carstens, J. L. et al. Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer. Nat. Commun. 8, 15095 (2017).","journal-title":"Nat. Commun."},{"key":"2777_CR88","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.cmet.2022.03.013","volume":"34","author":"M Wenes","year":"2022","unstructured":"Wenes, M. et al. The mitochondrial pyruvate carrier regulates memory T-cell differentiation and antitumor function. Cell Metab. 34, 731\u2013746.e739 (2022).","journal-title":"Cell Metab."},{"key":"2777_CR89","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adg8817","volume":"9","author":"S Ma","year":"2024","unstructured":"Ma, S. et al. Serine enrichment in tumors promotes regulatory T-cell accumulation through sphinganine-mediated regulation of c-Fos. Sci. Immunol. 9, eadg8817 (2024).","journal-title":"Sci. Immunol."},{"key":"2777_CR90","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.229","volume":"4","author":"FL Zeng","year":"2023","unstructured":"Zeng, F. L. et al. Interleukin-37 promotes DMBA\/TPA skin cancer through SIGIRR-mediated inhibition of glycolysis in CD103(+)DC cells. MedComm 4, e229 (2023).","journal-title":"MedComm"},{"key":"2777_CR91","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.cell.2021.01.010","volume":"184","author":"S Cheng","year":"2021","unstructured":"Cheng, S. et al. A pancancer single-cell transcriptional atlas of tumor infiltrating myeloid cells. Cell 184, 792\u2013809 e723 (2021).","journal-title":"Cell"},{"key":"2777_CR92","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.cell.2015.08.012","volume":"162","author":"PC Ho","year":"2015","unstructured":"Ho, P. C. et al. Phosphoenolpyruvate is a metabolic checkpoint of anti-tumor T-cell responses. Cell 162, 1217\u20131228 (2015).","journal-title":"Cell"},{"key":"2777_CR93","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.1182\/blood-2013-12-545772","volume":"124","author":"CT Mayer","year":"2014","unstructured":"Mayer, C. T. et al. Selective and efficient generation of functional Batf3-dependent CD103+ dendritic cells from mouse bone marrow. Blood 124, 3081\u20133091 (2014).","journal-title":"Blood"}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02777-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02777-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02777-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T23:01:07Z","timestamp":1785106867000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-026-02777-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,27]]},"references-count":93,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2777"],"URL":"https:\/\/doi.org\/10.1038\/s41392-026-02777-3","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,27]]},"assertion":[{"value":"20 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"We obtained consent to publish this paper from all the participants of this study.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"292"}}